From October 9 to 11, 2024, the Congrès de la Société Française de Médecine Prédictive et Personnalisée (SFMPP) brought together researchers, clinicians and innovative companies to discuss advances in oncogenomics, genomics and artificial intelligence.
As part of the session “START-UP PITCHS: Innovation in predictive and personalized medicine”, Genexpath presented its work and innovative solutions to improve the diagnosis of pathologies using genomics.
During this intervention, we addressed the following topic:
📌 “Custom RT-MLPSeq: how to characterize pathologies using a simple, turnkey expression signature.”
Diagnostic tools based on gene expression analysis offer promising prospects for better understanding and characterizing many pathologies, particularly in oncology. Genexpath is developing customized solutions that leverage RT-MLPSeq for rapid and accurate analysis of expression
Watch the replay of our intervention
We invite you to discover how Genexpath uses innovation in genomics to deliver more precise and personalized diagnosis.
To know more about Genexpath and our advances in genomic medicine, visit our site: 🌐 www.genexpath.com